Fig. 1From: Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experienceProgression-free survival Kaplan Meier estimates. Of note: three patients received a second chemosaturation therapy without evidence of progressive diseaseBack to article page